Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Amoxycillin (1000mg) + Clavulanic Acid (200mg)
Therapeutic Category
Antibacterials, Antibiotic, Pediatrics, ENT
Dosage Form
Injection
Packaging Type
vial
Packaging
1.2gm
Price
₹147/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxyplit CV 1.2 Injection is a combination antibiotic formulation containing Amoxycillin and Clavulanic Acid, designed to treat a wide range of bacterial infections. Amoxycillin, a penicillin-type antibiotic, works by inhibiting the growth of bacteria by interfering with their cell wall synthesis. Clavulanic Acid, a beta-lactamase inhibitor, prevents certain bacteria from breaking down Amoxycillin, thus enhancing its effectiveness against a broader spectrum of bacterial strains, including resistant ones.
This combination therapy is effective in treating various infections, including respiratory tract infections (like pneumonia and bronchitis), urinary tract infections, skin infections, and intra-abdominal infections. It is also used in managing infections associated with surgical procedures and in complicated or resistant bacterial infections.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Moxyplit CV 1.2 Injection Prescribed for bacterial infections in lungs, ear, sinuses, urinary tract, skin, and soft tissues; ineffective for viral infections.
Information regarding the use of Moxyplit CV 1.2 Injection during breastfeeding is not available. Please consult your doctor.
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)
Composition : Arteether (150mg) Injection
Composition : Artesunate (120mg) Injection
Composition : Artesunate (60mg) Injection
Composition : Azithromycin (500mg) Injection
Composition : Brivaracetam (10mg) Injection
Composition : Cefepime (1000mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This high-strength injectable antibiotic combination has strong demand in the hospital and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-infective and institutional care portfolios.
Medical distributors and agencies can benefit from consistent hospital demand for treatment of severe respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, post-surgical infections, and other serious bacterial infections. Amoxycillin fights infection-causing bacteria, while Clavulanic Acid enhances antibiotic effectiveness by preventing bacterial resistance, strengthening a reliable injectable antibiotic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this injectable antibiotic combination with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital and ICU demand, institutional bulk orders, high anti-infective prescription usage, reliable supply chain support, and good margins when partnering for this injectable antibiotic product.
Medical distributors, stockists, and wholesalers interested in this injectable antibiotic combination can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.